相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status
Gurpreet S. Kapoor et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Novel Genomic Alterations and Mechanisms Associated With Tumor Progression in Oligodendroglioma and Mixed Oligoastrocytoma
David Blesa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas
Timo Gaiser et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
Izabela Zawlik et al.
NEUROEPIDEMIOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study
M. Wager et al.
BRITISH JOURNAL OF CANCER (2008)
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples
Koji Yoshimoto et al.
CLINICAL CANCER RESEARCH (2008)
Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis
Sreekanth P. Reddy et al.
CLINICAL CANCER RESEARCH (2008)
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma
Robert Brown et al.
CLINICAL CANCER RESEARCH (2008)
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss
Markus J. Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular diagnostic testing in malignant gliomas: A practical update on predictive markers
Stephen Yip et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities
Charles B. Stevenson et al.
NEUROSURGERY (2008)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
Maximilian Diehn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps
Kyrre E. Emblem et al.
RADIOLOGY (2008)
Relationship between gene expression and enhancement in glioblastoma multiforme: Exploratory DNA microarray analysis
Whitney B. Pope et al.
RADIOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
John H. Sampson et al.
SEMINARS IN IMMUNOLOGY (2008)
Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma
Satoshi Nakasu et al.
SURGICAL NEUROLOGY (2007)
MRI contrast agents for functional molecular imaging of brain activity
Alan Jasanoff
CURRENT OPINION IN NEUROBIOLOGY (2007)
From expert opinion to evidence-based: changes in the gold standard of primary brain tumour diagnosis
J. M. Kros
JOURNAL OF PATHOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion
Meng Law et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
Dynamic history of low-grade gliomas before and after temozolomide treatment
Damien Ricard et al.
ANNALS OF NEUROLOGY (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival
Marica Eoli et al.
CLINICAL CANCER RESEARCH (2007)
Relationship between survival and edema in malignant gliomas: Role of vascular endothelial growth factor and neuronal pentraxin 2
Marc R. J. Carlson et al.
CLINICAL CANCER RESEARCH (2007)
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas
Teri-T B. Ngo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CHD5 is a tumor suppressor at human 1p36
Anindya Bagchi et al.
CELL (2007)
Imaging cerebral gene transcripts in live animals
Christina H. Liu et al.
JOURNAL OF NEUROSCIENCE (2007)
Genetic aberrations in gliomatosis cerebri
Marcus L. Ware et al.
NEUROSURGERY (2007)
Molecular imaging of brain tumors: A bridge between clinical and molecular medicine?
B. J. Schaller et al.
MOLECULAR IMAGING AND BIOLOGY (2007)
Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets
Timothy Van Meter et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
1p/19q chromosome deletions in metastatic oligodendroglioma
Ryan Merrell et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
Robert B. Jenkins et al.
CANCER RESEARCH (2006)
Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy
Luigi Mariani et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reclassification of oligoastrocytomas by loss of heterozygosity studies
Marica Eoli et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma
M Aghi et al.
CLINICAL CANCER RESEARCH (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
From the archives of the AFIP - Oligodendroglioma and its variants: Radiologic-pathologic correlation
KK Koeller et al.
RADIOGRAPHICS (2005)
Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas
L Montanini et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
DA Haas-Kogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: Visual evaluation of brain tumors
T Kubota et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2005)
Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors
M Möllemann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival
J Felsberg et al.
BRAIN PATHOLOGY (2004)
Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization grade II astrocytoma or oligoastrocytoma -: A long-term analysis
M Ständer et al.
CANCER (2004)
Imaging correlates of molecular signatures in oligodendrogliomas
JF Megyesi et al.
CLINICAL CANCER RESEARCH (2004)
Ancillary fish analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics
A Perry et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
K Hoang-Xuan et al.
NEUROLOGY (2001)
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C→A:T mutations of the TP53 tumor suppressor gene
M Nakamura et al.
CARCINOGENESIS (2001)
分享论文
